Aligning RI KPIs with Corporate Risk Appetite and Strategy Aligning Regulatory Intelligence KPIs with Corporate Risk Appetite and Strategy In the ever-evolving landscape of pharmaceutical and biotech regulatory affairs, the establishment of robust regulatory intelligence dashboards and KPIs is paramount for aligning compliance efforts with corporate strategy and risk appetite. This article serves as a detailed regulatory explainer manual aimed at Kharma and regulatory professionals, outlining relevant regulations, guidelines, and agency expectations that govern the integration of regulatory intelligence into business decision-making. Context Regulatory intelligence (RI) involves the collection, analysis, and dissemination of information regarding regulations, guidelines, and policies that…

Automating regular RI reporting cycles with BI tools Automating Regular RI Reporting Cycles with BI Tools In the rapidly evolving landscape of global pharmaceutical and biotechnology regulation, the integration of Business Intelligence (BI) tools to automate reporting cycles is essential. Regulatory Intelligence (RI) dashboards and Key Performance Indicators (KPIs) play a critical role in informing senior management and boards about compliance, performance, and risk management. This article serves as a comprehensive guide for Regulatory Affairs (RA) professionals on the implementation and optimization of regulatory intelligence frameworks that leverage BI tools. Regulatory Affairs Context Regulatory Affairs professionals are tasked with ensuring…

Balancing detail versus clarity in RI slide decks and packs Balancing Detail Versus Clarity in Regulatory Intelligence Slide Decks and Packs Context Regulatory Affairs (RA) professionals face the challenge of translating complex regulatory requirements and data into concise and effective communication tools. Among these tools, Regulatory Intelligence (RI) dashboards and KPIs are vital for senior management and boards. They serve as fundamental elements in decision-making processes, particularly in ensuring compliance with regulatory frameworks such as those established by the FDA, EMA, and MHRA. This article elaborates on how to strike a balance between detail and clarity while developing RI slide…

Using RI dashboards to support capital allocation and portfolio moves Using Regulatory Intelligence Dashboards to Support Capital Allocation and Portfolio Moves In the dynamic realm of pharmaceutical and biotech industries, effective regulatory affairs (RA) practices play a crucial role in capital allocation and portfolio management. This extensive manual delves into the significance of regulatory intelligence (RI) dashboards, providing a structured overview of relevant regulations, guidelines, and agency expectations across the US, UK, and EU. This guide is designed for regulatory professionals aiming to enhance organizational decision-making through robust reporting and visualization tools. Regulatory Affairs Context Regulatory Affairs professionals are tasked…

Continuous improvement of RI KPIs based on leadership feedback Continuous improvement of RI KPIs based on leadership feedback Introduction to Regulatory Intelligence (RI) Regulatory Intelligence (RI) plays a critical role in the pharmaceutical and biotech industries, serving as a foundation for compliance and strategic decision-making. At its core, RI involves the systematic collection, analysis, and dissemination of regulatory data, which includes guidelines, industry standards, and agency communications. With the rapidly evolving landscape of regulations, maintaining effective regulatory intelligence is a necessity for successful product development and commercialization. Legal and Regulatory Basis for RI KPIs The context of RI is established…